CIMEX
Price
$27.36
Change
+$0.09 (+0.33%)
Updated
Jun 2 closing price
Net Assets
146.54B
HRLRX
Price
$11.04
Change
+$0.05 (+0.45%)
Updated
Jun 2 closing price
Net Assets
67.76M
Interact to see
Advertisement

CIMEX vs HRLRX

Header iconCIMEX vs HRLRX Comparison
Open Charts CIMEX vs HRLRXBanner chart's image
CIMEX vs HRLRX Comparison Chart in %
View a ticker or compare two or three
VS
CIMEX vs. HRLRX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMEX is a Buy and HRLRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMEX has more cash in the bank: 147B vs. HRLRX (67.8M). CIMEX pays higher dividends than HRLRX: CIMEX (3.23) vs HRLRX (2.92). CIMEX was incepted earlier than HRLRX: CIMEX (24 years) vs HRLRX (16 years). HRLRX (2.01) is less costly to investors than CIMEX (0.83). HRLRX is a more actively managed with annual turnover of: 149.00 vs. CIMEX (65.00). HRLRX has a lower initial minimum investment than CIMEX: HRLRX (0) vs CIMEX (250). HRLRX annual gain was more profitable for investors over the last year : 23.66 vs. CIMEX (8.61). HRLRX return over 5 years is better than : 44.02 vs. CIMEX (23.26).
CIMEXHRLRXCIMEX / HRLRX
Total Expense Ratio0.831.5055%
Annual Report Gross Expense Ratio0.832.0141%
Fund Existence24 years16 years-
Gain YTD5.85113.18244%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets147B67.8M216,814%
Annual Yield % from dividends3.232.92111%
Returns for 1 year8.6123.6636%
Returns for 3 years35.1342.0084%
Returns for 5 years23.2644.0253%
Returns for 10 years76.5486.1589%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLPCX17.86N/A
N/A
JPMorgan US Large Cap Core Plus C
PICMX40.22N/A
N/A
Virtus KAR Mid-Cap Growth I
OIEJX26.85N/A
N/A
JPMorgan Equity Income R6
MXISX14.85N/A
N/A
Empower S&P SmallCap 600® Index Inv
RYOAX61.16N/A
N/A
Rydex Biotechnology H